NASDAQ:EPIX - ESSA Pharma Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$3.28 -0.11 (-3.24 %)
(As of 05/22/2018 04:00 PM ET)
Previous Close$3.28
Today's Range$3.05 - $3.28
52-Week Range$2.00 - $51.00
Volume12,845 shs
Average Volume13,477 shs
Market Capitalization$20.50 million
P/E Ratio-0.41
Dividend YieldN/A
Beta1.68

About ESSA Pharma (NASDAQ:EPIX)

ESSA Pharma logoESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on the development of novel therapeutics for the treatment of prostate cancer. It is developing EPI-506 that is in Phase 1/2 clinical trials for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

Receive EPIX News and Ratings via Email

Sign-up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:EPIX
CUSIPN/A
Phone778-331-0962

Debt

Debt-to-Equity Ratio0.35
Current Ratio5.29
Quick Ratio5.29

Price-To-Earnings

Trailing P/E Ratio-0.41
Forward P/E Ratio-0.98
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value($3.09) per share
Price / Book-1.06

Profitability

EPS (Most Recent Fiscal Year)($8.00)
Net Income$-4,720,000.00
Net MarginsN/A
Return on Equity-13,659.00%
Return on Assets-137.41%

Miscellaneous

Employees15
Outstanding Shares5,780,000

ESSA Pharma (NASDAQ:EPIX) Frequently Asked Questions

What is ESSA Pharma's stock symbol?

ESSA Pharma trades on the NASDAQ under the ticker symbol "EPIX."

How were ESSA Pharma's earnings last quarter?

ESSA Pharma (NASDAQ:EPIX) issued its quarterly earnings results on Monday, May, 14th. The company reported ($0.83) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.40) by $0.43. View ESSA Pharma's Earnings History.

When is ESSA Pharma's next earnings date?

ESSA Pharma is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for ESSA Pharma.

What price target have analysts set for EPIX?

3 Wall Street analysts have issued 1 year price objectives for ESSA Pharma's shares. Their predictions range from $0.70 to $0.70. On average, they expect ESSA Pharma's share price to reach $0.70 in the next year. View Analyst Ratings for ESSA Pharma.

Who are some of ESSA Pharma's key competitors?

Who are ESSA Pharma's key executives?

ESSA Pharma's management team includes the folowing people:
  • Dr. David Ross Parkinson, Pres, CEO & Director (Age 68)
  • Mr. David S. Wood, CFO & Principal Accounting Officer (Age 61)
  • Mr. Peter A. Virsik, Exec. VP & COO (Age 47)
  • Dr. Raymond Andersen, CTO, Sec. & Director (Age 71)
  • Dr. Marianne D. Sadar, Chief Scientific Officer & Director (Age 57)

Has ESSA Pharma been receiving favorable news coverage?

News articles about EPIX stock have been trending somewhat positive recently, according to Accern Sentiment. Accern scores the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. ESSA Pharma earned a news sentiment score of 0.13 on Accern's scale. They also assigned news coverage about the company an impact score of 46.69 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of ESSA Pharma?

Shares of EPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ESSA Pharma's stock price today?

One share of EPIX stock can currently be purchased for approximately $3.28.

How big of a company is ESSA Pharma?

ESSA Pharma has a market capitalization of $20.50 million. The company earns $-4,720,000.00 in net income (profit) each year or ($8.00) on an earnings per share basis. ESSA Pharma employs 15 workers across the globe.

How can I contact ESSA Pharma?

ESSA Pharma's mailing address is 999 WEST BROADWAY SUITE 720, VANCOUVER A1, V5Z 1K5. The company can be reached via phone at 778-331-0962.


MarketBeat Community Rating for ESSA Pharma (EPIX)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  120 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  196
MarketBeat's community ratings are surveys of what our community members think about ESSA Pharma and other stocks. Vote "Outperform" if you believe EPIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EPIX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ESSA Pharma (NASDAQ:EPIX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for ESSA Pharma in the last 12 months. Their average twelve-month price target is $0.70, suggesting that the stock has a possible downside of 78.66%. The high price target for EPIX is $0.70 and the low price target for EPIX is $0.70. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.002.67
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $0.70$0.70N/A$9.00
Price Target Upside: 78.66% downside250.00% upsideN/A2,854.69% upside

ESSA Pharma (NASDAQ:EPIX) Consensus Price Target History

Price Target History for ESSA Pharma (NASDAQ:EPIX)

ESSA Pharma (NASDAQ:EPIX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/26/2018HC WainwrightInitiated CoverageBuy$0.70MediumView Rating Details
1/18/2018Bloom BurtonUpgradeHold ➝ BuyHighView Rating Details
8/3/2017Dawson JamesReiterated RatingBuyHighView Rating Details
2/17/2017Noble FinancialInitiated CoverageBuy$9.00N/AView Rating Details
(Data available from 5/22/2016 forward)

Earnings

ESSA Pharma (NASDAQ:EPIX) Earnings History and Estimates Chart

Earnings by Quarter for ESSA Pharma (NASDAQ:EPIX)

ESSA Pharma (NASDAQ:EPIX) Earnings Estimates

Current Year EPS Consensus Estimate: $-3.34 EPS
Next Year EPS Consensus Estimate: $-2.06 EPS

ESSA Pharma (NASDAQ EPIX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/13/2018        
5/14/2018Q2 2018($0.40)($0.83)ViewN/AView Earnings Details
2/13/2018Q1 2018($0.07)ViewN/AView Earnings Details
12/11/2017Q4 2017($0.09)ViewN/AView Earnings Details
8/14/2017Q3 2017($0.17)($0.16)ViewN/AView Earnings Details
5/15/2017Q2 2017($0.11)($0.26)ViewN/AView Earnings Details
2/13/2017Q1 2017$0.05ViewN/AView Earnings Details
12/14/2016Q4 2016($0.19)ViewN/AView Earnings Details
8/12/2016Q3 2016($0.13)ViewN/AView Earnings Details
5/13/2016Q2 2016($0.20)ViewN/AView Earnings Details
2/12/2016Q1 2016($0.18)ViewN/AView Earnings Details
12/14/2015Q4 2015$0.02ViewN/AView Earnings Details
8/17/2015Q3 2015($0.28)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

ESSA Pharma (NASDAQ:EPIX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

ESSA Pharma (NASDAQ EPIX) Insider Trading and Institutional Ownership History

Insider Trading History for ESSA Pharma (NASDAQ:EPIX)

ESSA Pharma (NASDAQ EPIX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

ESSA Pharma (NASDAQ EPIX) News Headlines

Source:
DateHeadline
 ESSA Pharma (EPIX) Given Average Rating of "Strong Buy" by Analysts ESSA Pharma (EPIX) Given Average Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - May 18 at 1:06 AM
ESSA Pharma (EPIX) Downgraded by Zacks Investment Research to "Hold"ESSA Pharma (EPIX) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - May 15 at 10:58 PM
HC Wainwright Reiterates "Buy" Rating for ESSA Pharma (EPIX)HC Wainwright Reiterates "Buy" Rating for ESSA Pharma (EPIX)
www.americanbankingnews.com - May 15 at 11:34 AM
ESSA Pharma: Fiscal 2Q Earnings SnapshotESSA Pharma: Fiscal 2Q Earnings Snapshot
www.cnbc.com - May 15 at 10:59 AM
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018
finance.yahoo.com - May 15 at 10:59 AM
ESSA Pharma reports Q2 resultsESSA Pharma reports Q2 results
seekingalpha.com - May 14 at 11:51 PM
Zacks: Brokerages Anticipate ESSA Pharma (EPIX) to Announce -$0.40 EPSZacks: Brokerages Anticipate ESSA Pharma (EPIX) to Announce -$0.40 EPS
www.americanbankingnews.com - May 12 at 10:49 AM
ESSA Pharma (EPIX) Lifted to Buy at Zacks Investment ResearchESSA Pharma (EPIX) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - May 10 at 10:52 PM
Essa Pharma Inc. Regains Compliance with NASDAQ Listing RequirementsEssa Pharma Inc. Regains Compliance with NASDAQ Listing Requirements
www.prnewswire.com - May 10 at 5:28 PM
ValuEngine Upgrades ESSA Pharma (EPIX) to HoldValuEngine Upgrades ESSA Pharma (EPIX) to Hold
www.americanbankingnews.com - May 4 at 12:12 AM
Analysts Anticipate ESSA Pharma (EPIX) to Post ($0.40) Earnings Per ShareAnalysts Anticipate ESSA Pharma (EPIX) to Post ($0.40) Earnings Per Share
www.americanbankingnews.com - May 2 at 11:19 PM
Contrasting ESSA Pharma (EPIX) & Its PeersContrasting ESSA Pharma (EPIX) & Its Peers
www.americanbankingnews.com - April 27 at 8:52 AM
ESSA Pharma (EPIX) Downgraded by Zacks Investment Research to HoldESSA Pharma (EPIX) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - April 24 at 10:46 PM
Zacks: Analysts Anticipate ESSA Pharma (EPIX) to Post -$0.02 Earnings Per ShareZacks: Analysts Anticipate ESSA Pharma (EPIX) to Post -$0.02 Earnings Per Share
www.americanbankingnews.com - April 24 at 7:20 PM
ESSA Pharma Inc. Announces Share ConsolidationESSA Pharma Inc. Announces Share Consolidation
www.prnewswire.com - April 19 at 7:48 PM
Brokerages Anticipate ESSA Pharma Inc. (EPIX) to Announce ($0.02) Earnings Per ShareBrokerages Anticipate ESSA Pharma Inc. (EPIX) to Announce ($0.02) Earnings Per Share
www.americanbankingnews.com - April 16 at 9:25 AM
Contrasting ESSA Pharma (EPIX) & Nektar Therapeutics (NKTR)Contrasting ESSA Pharma (EPIX) & Nektar Therapeutics (NKTR)
www.americanbankingnews.com - April 15 at 9:25 AM
Does ESSA Pharma Inc (CVE:EPI) Go Up With The Market?Does ESSA Pharma Inc (CVE:EPI) Go Up With The Market?
finance.yahoo.com - April 12 at 11:18 AM
ESSA Pharma (EPIX) versus Its Peers Head to Head ReviewESSA Pharma (EPIX) versus Its Peers Head to Head Review
www.americanbankingnews.com - April 8 at 5:19 AM
-$0.02 Earnings Per Share Expected for ESSA Pharma Inc. (EPIX) This Quarter-$0.02 Earnings Per Share Expected for ESSA Pharma Inc. (EPIX) This Quarter
www.americanbankingnews.com - April 7 at 9:23 PM
ESSA Pharma (EPIX) Upgraded by Zacks Investment Research to BuyESSA Pharma (EPIX) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - April 4 at 12:34 AM
Zacks: Brokerages Set $3.07 Price Target for ESSA Pharma Inc. (EPIX)Zacks: Brokerages Set $3.07 Price Target for ESSA Pharma Inc. (EPIX)
www.americanbankingnews.com - March 30 at 1:20 PM
Zacks Investment Research Downgrades ESSA Pharma (EPIX) to HoldZacks Investment Research Downgrades ESSA Pharma (EPIX) to Hold
www.americanbankingnews.com - March 29 at 12:00 AM
ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of ShareholdersESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders
www.prnewswire.com - March 28 at 11:30 PM
ESSA Pharma (EPIX) Rating Increased to Buy at Zacks Investment ResearchESSA Pharma (EPIX) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - March 28 at 12:58 PM
ESSA Pharma (EPIX) Now Covered by HC WainwrightESSA Pharma (EPIX) Now Covered by HC Wainwright
www.americanbankingnews.com - March 26 at 8:39 AM
ESSA Pharma (EPIX) Upgraded to Sell by ValuEngineESSA Pharma (EPIX) Upgraded to Sell by ValuEngine
www.americanbankingnews.com - March 25 at 6:25 PM
 ESSA Pharma Inc. (EPIX) Given Consensus Recommendation of "Strong Buy" by Brokerages ESSA Pharma Inc. (EPIX) Given Consensus Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - March 15 at 11:30 AM
Zacks: ESSA Pharma Inc. (EPIX) Given $4.25 Average Price Target by AnalystsZacks: ESSA Pharma Inc. (EPIX) Given $4.25 Average Price Target by Analysts
www.americanbankingnews.com - March 4 at 3:10 PM
 ESSA Pharma Inc. (EPIX) Given $4.25 Consensus Target Price by Brokerages ESSA Pharma Inc. (EPIX) Given $4.25 Consensus Target Price by Brokerages
www.americanbankingnews.com - February 26 at 3:20 PM
ESSA Pharma Inc. (EPIX) Expected to Earn FY2018 Earnings of ($0.08) Per ShareESSA Pharma Inc. (EPIX) Expected to Earn FY2018 Earnings of ($0.08) Per Share
www.americanbankingnews.com - February 23 at 12:50 PM
ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option GrantsESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants
finance.yahoo.com - February 23 at 10:23 AM
Zacks: Brokerages Set $5.10 Price Target for ESSA Pharma Inc. (EPIX)Zacks: Brokerages Set $5.10 Price Target for ESSA Pharma Inc. (EPIX)
www.americanbankingnews.com - February 18 at 11:12 PM
ESSA Pharma reports 1Q lossESSA Pharma reports 1Q loss
www.cnbc.com - February 14 at 8:36 AM
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017
finance.yahoo.com - February 13 at 5:04 PM
What Bargain Hunting? Bet on 6 Stocks With Rising P/EWhat Bargain Hunting? Bet on 6 Stocks With Rising P/E
finance.yahoo.com - February 7 at 8:32 AM
Zacks Investment Research Upgrades ESSA Pharma (EPIX) to "Buy"Zacks Investment Research Upgrades ESSA Pharma (EPIX) to "Buy"
www.americanbankingnews.com - February 6 at 11:06 PM
ESSA Pharma (EPIX) Cut to Hold at Zacks Investment ResearchESSA Pharma (EPIX) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - February 5 at 11:24 PM
 ESSA Pharma Inc. (EPIX) Given Consensus Rating of "Strong Buy" by Analysts ESSA Pharma Inc. (EPIX) Given Consensus Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - February 1 at 1:12 AM
 ESSA Pharma Inc. (EPIX) Given $5.10 Average Target Price by Brokerages ESSA Pharma Inc. (EPIX) Given $5.10 Average Target Price by Brokerages
www.americanbankingnews.com - January 26 at 9:14 PM
ESSA to Present at Noble Capital Markets NobleCon14ESSA to Present at Noble Capital Markets' NobleCon14
finance.yahoo.com - January 26 at 8:33 AM
 ESSA Pharma Inc. (EPIX) Given Average Rating of "Buy" by Analysts ESSA Pharma Inc. (EPIX) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - January 21 at 5:24 AM
ESSA Pharma (EPIX) Upgraded at Bloom BurtonESSA Pharma (EPIX) Upgraded at Bloom Burton
www.americanbankingnews.com - January 20 at 6:28 AM
ESSA expects 180-day extension to regain compliance with the Nasdaq Bid Price RuleESSA expects 180-day extension to regain compliance with the Nasdaq Bid Price Rule
www.prnewswire.com - January 16 at 10:19 PM
Zacks: ESSA Pharma Inc. (EPIX) Given Consensus Recommendation of "Buy" by AnalystsZacks: ESSA Pharma Inc. (EPIX) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - January 5 at 7:24 PM
 ESSA Pharma Inc. (EPIX) Receives Average Recommendation of "Buy" from Brokerages ESSA Pharma Inc. (EPIX) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - December 21 at 5:12 PM
 ESSA Pharma Inc. (EPIX) Given $5.10 Consensus Target Price by Analysts ESSA Pharma Inc. (EPIX) Given $5.10 Consensus Target Price by Analysts
www.americanbankingnews.com - December 5 at 11:36 PM
 ESSA Pharma Inc. (EPIX) Given $5.10 Average Price Target by Analysts ESSA Pharma Inc. (EPIX) Given $5.10 Average Price Target by Analysts
www.americanbankingnews.com - December 2 at 9:34 AM
 Analysts Anticipate ESSA Pharma Inc. (EPIX) to Post -$0.18 EPS Analysts Anticipate ESSA Pharma Inc. (EPIX) to Post -$0.18 EPS
www.americanbankingnews.com - November 22 at 3:16 AM
Zacks: ESSA Pharma Inc. (EPIX) Receives Consensus Recommendation of "Buy" from AnalystsZacks: ESSA Pharma Inc. (EPIX) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - November 16 at 3:36 PM

SEC Filings

ESSA Pharma (NASDAQ:EPIX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

ESSA Pharma (NASDAQ:EPIX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

ESSA Pharma (NASDAQ EPIX) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.